PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
UTHR vs. CTLT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between UTHR and CTLT is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

UTHR vs. CTLT

Last updated May 30, 2025

Compare and contrast key facts about United Therapeutics Corporation (UTHR) and Catalent, Inc. (CTLT).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: UTHR or CTLT.

Performance

UTHR vs. CTLT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Catalent, Inc. (CTLT). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Fundamentals

Market Cap

UTHR:

$14.45B

CTLT:

$11.52B

EPS

UTHR:

$25.47

CTLT:

-$2.28

PEG Ratio

UTHR:

1.43

CTLT:

529.00

PS Ratio

UTHR:

4.83

CTLT:

2.61

PB Ratio

UTHR:

2.09

CTLT:

3.25

Total Revenue (TTM)

UTHR:

$2.99B

CTLT:

$2.32B

Gross Profit (TTM)

UTHR:

$2.66B

CTLT:

$565.00M

EBITDA (TTM)

UTHR:

$1.56B

CTLT:

$346.00M

Returns By Period

UTHR

YTD

-9.20%

1M

6.52%

6M

-15.28%

1Y

19.67%

3Y*

10.75%

5Y*

22.12%

10Y*

5.81%

CTLT

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

United Therapeutics Corporation

Catalent, Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

UTHR vs. CTLT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
UTHR
The Risk-Adjusted Performance Rank of UTHR is 6868
Overall Rank
The Sharpe Ratio Rank of UTHR is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of UTHR is 6262
Sortino Ratio Rank
The Omega Ratio Rank of UTHR is 6464
Omega Ratio Rank
The Calmar Ratio Rank of UTHR is 7373
Calmar Ratio Rank
The Martin Ratio Rank of UTHR is 6666
Martin Ratio Rank
CTLT
The Risk-Adjusted Performance Rank of CTLT is 9292
Overall Rank
The Sharpe Ratio Rank of CTLT is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of CTLT is 9898
Sortino Ratio Rank
The Omega Ratio Rank of CTLT is 9898
Omega Ratio Rank
The Calmar Ratio Rank of CTLT is 7676
Calmar Ratio Rank
The Martin Ratio Rank of CTLT is 9494
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UTHR vs. CTLT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Catalent, Inc. (CTLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

UTHR vs. CTLT - Dividend Comparison

Neither UTHR nor CTLT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

UTHR vs. CTLT - Drawdown Comparison

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

UTHR vs. CTLT - Volatility Comparison

Loading data...

Financials

UTHR vs. CTLT - Financials Comparison

This section allows you to compare key financial metrics between United Therapeutics Corporation and Catalent, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

400.00M600.00M800.00M1.00B1.20B1.40B20212022202320242025
794.40M
1.02B
(UTHR) Total Revenue
(CTLT) Total Revenue
Values in USD except per share items